Paper8306366
Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
Landmann R and 7 others. Cancer Immunol Immunother, 1994. Cited by 15 papers, by iCite.
Cite this record
ConductScience Library. Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha. Papers, record 8306366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8306366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Interferon-alpha | Major topic |
| Receptors, Tumor Necrosis Factor | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Adult | |
| Aged | |
| Carcinoma | |
| Carcinoma, Renal Cell | |
| Female | |
| Humans | |
| Immunotherapy | |
| Interleukin-2 | |
| Male | |
| Melanoma | |
| Middle Aged | |
| Recombinant Proteins | |
| Skin Neoplasms | |
| Solubility | |
| Thyroid Neoplasms |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 3040886 | Effect of tumor necrosis factor alpha on mitogen-activated human B cells. | J Exp Med | 1987 | https://conductscience.org/library/papers/3040886 | PubMed |
| 2 | 3147899 | Monocytic production and plasma bioactivities of interleukin-1 and tumour necrosis factor in human cancer. | Eur J Clin Invest | 1988 | https://conductscience.org/library/papers/3147899 | PubMed |
| 3 | 1655258 | Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. | Cancer Res | 1991 | https://conductscience.org/library/papers/1655258 | PubMed |
| 4 | 1544123 | Regional administration of lymphokine-activated killer cells can be superior to intravenous application. | Cancer | 1992 | https://conductscience.org/library/papers/1544123 | PubMed |
| 5 | 3285747 | NIH conference. New approaches to the immunotherapy of cancer using interleukin-2. | Ann Intern Med | 1988 | https://conductscience.org/library/papers/3285747 | PubMed |
| 6 | 2661690 | Induction of endogenous cytokine-mRNA in circulating peripheral blood mononuclear cells by IL-2 administration to cancer patients. | J Immunol | 1989 | https://conductscience.org/library/papers/2661690 | PubMed |
| 7 | 3928750 | Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. | J Immunol | 1985 | https://conductscience.org/library/papers/3928750 | PubMed |
| 8 | 1322942 | Release of soluble receptors for tumor necrosis factor (TNF) in relation to circulating TNF during experimental endotoxinemia. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1322942 | PubMed |
| 9 | 1321854 | Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. | J Immunol | 1992 | https://conductscience.org/library/papers/1321854 | PubMed |
| 10 | 1649557 | Tumor necrosis factor receptors in lymphoid tissues and lymphomas. Source and site of action of tumor necrosis factor alpha. | Am J Pathol | 1991 | https://conductscience.org/library/papers/1649557 | PubMed |
| 11 | 8443808 | A direct comparison of immunological and clinical effects of interleukin 2 with and without interferon-alpha in humans. | Cancer Res | 1993 | https://conductscience.org/library/papers/8443808 | PubMed |
| 12 | 2506138 | Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells. | Int J Cancer | 1989 | https://conductscience.org/library/papers/2506138 | PubMed |
| 13 | 3265420 | Induction of circulating tumor necrosis factor (TNF alpha) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients. | J Clin Immunol | 1988 | https://conductscience.org/library/papers/3265420 | PubMed |
| 14 | 2160731 | A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. | Science | 1990 | https://conductscience.org/library/papers/2160731 | PubMed |
| 15 | 1997108 | Clinical and immune modulatory effects of alternative weekly interleukin-2 and interferon alfa-2a in patients with advanced renal cell carcinoma and melanoma. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1997108 | PubMed |
| 16 | 1707931 | Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells. | J Immunol | 1991 | https://conductscience.org/library/papers/1707931 | PubMed |
| 17 | 2457708 | Human natural cytotoxic activity mediated by tumor necrosis factor: regulation by interleukin-2. | J Natl Cancer Inst | 1988 | https://conductscience.org/library/papers/2457708 | PubMed |
| 18 | 8319195 | Interferon-alpha and interleukin-2 in the treatment of metastatic melanoma. Comparison of two phase II trials. | Cancer | 1993 | https://conductscience.org/library/papers/8319195 | PubMed |
| 19 | 1969983 | Spontaneous production of tumour necrosis factor alpha and interleukin-1 beta during interferon-alpha treatment of chronic HBV infection. | Lancet | 1990 | https://conductscience.org/library/papers/1969983 | PubMed |
| 20 | 3798026 | Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients. | Scand J Immunol | 1986 | https://conductscience.org/library/papers/3798026 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22451470 | Total and abdominal adiposity are associated with inflammation in older adults using a factor analysis approach. | J Gerontol A Biol Sci Med Sci | 2012 | https://conductscience.org/library/papers/22451470 | PubMed |
| 21632552 | Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma. | Cancer Res | 2011 | https://conductscience.org/library/papers/21632552 | PubMed |
| 9708191 | Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I. | Immunology | 1998 | https://conductscience.org/library/papers/9708191 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IL2 | 3558 | PubTator's text mining | https://conductscience.org/library/genes/3558 | NCBI Gene |
| IL2RA | 3559 | PubTator's text mining | https://conductscience.org/library/genes/3559 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
| TNFRSF1B | 7133 | PubTator's text mining | https://conductscience.org/library/genes/7133 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8306366
GET https://conductscience.org/api/papers/v1/8306366/references?page=2